Holbrook Larry
Chief Research Officer
Regulatory Affairs
CanniMed
Canada
Biography
Dr. Holbrook is a senior research scientist and currently Chief Research Officer of the Company, with expertise in cellular and basic molecular biology experimentation and more than 35 years of experience in research and application related to the genetic modification of crop plants with diverse agricultural biotechnology experience in both government and industry. His extensive plant research includes tissue culture, plant breeding, genetic transformation, microscopy, phytohormone and senescence biochemistry. Dr. Holbrook was an associate adjunct professor at the University of Calgary, Department of Biological Sciences from 1997 to 2003 and has authored or co-authored nearly 40 publications, reviews or invited papers in international journals and books. His experience includes leadership roles in four agricultural biotechnology start-up companies in Canada and as a committee member on a North American industry group, BIO, he assisted in developing industry points to consider in white paper proposals for producing plantmade pharmaceuticals (PMPs). He has worked in the medical marijuana field for the past 13 years at the Company leading research developments plus associations with clinical studies initiatives and the QA/QC department functions. Dr. Holbrook holds B.Sc., M.Sc. and a Ph.D. in Neuropharmacology and Developmental Biology from the University of Toronto and postdoctoral research at the UCLA School of Medicine, Brain Research Institute.
Research Interest
agricultural biotechnology